Schulman AMY W
SEC-identified person · CIK 1438226 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Alnylam Pharmaceuticals, INC. ALNY | Director | filed 2014–2026 |
| Wellpoint, INC WLP | Director | filed 2026–2026 |
| Camp4 Therapeutics Corp CAMP | Officer | filed 2024–2025 |
| Fractyl Health, Inc. GUTS | Director | filed 2024–2025 |
| SQZ Biotechnologies Co SQZ | Director | filed 2020–2023 |
| Hudson Executive Investment Corp. II HCII | Director | filed 2021–2021 |
| Cyclerion Therapeutics, Inc. [CYCN] | Director | filed 2019–2020 |
| Talkspace, Inc. TALK | Director | filed 2020–2020 |
| Ironwood Pharmaceuticals INC IRWD | Director | filed 2017–2019 |
| X4 Pharmaceuticals, Inc XFOR | Director | filed 2017–2018 |
| Blue Buffalo Pet Products, Inc. BUFF | Director | filed 2015–2018 |
| Dnib Unwind, INC. BIND | Director | filed 2014–2015 |
| Pfizer INC pfe | Senior Vice President | filed 2008–2014 |
| Zoetis Inc. ZTS | Director | filed 2013–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.